{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-078887","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2026-07-17T01:50:00+00:00","discovered_at":"2026-07-17T10:05:00.320988+00:00","generated_at":"2026-07-17T10:05:27.391968+00:00","sec_items":["1.01","5.03","2.01","3.02","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Jasper Therapeutics acquires Kira Pharmaceuticals; issues ~9.8M shares and raises $132M PIPE","bullets":["Jasper issued ~5.2M common shares and ~4.6M convertible preferred shares to Kira shareholders; Kira holders own ~88.73% of pro forma common pre-PIPE.","Concurrent $132M PIPE from sale of ~4.7M preferred shares (convertible into 61 common each) to new investors; closing expected July 20, 2026.","Pre-merger Jasper shareholders receive one CVR per share entitling to pro rata share of $30M if FDA issues Priority Review Voucher for briquilimab by Dec 31, 2028.","Kira subsidiary entered Mirador License Agreement for anti-C5a assets; $12M upfront, up to $458.5M milestones, low-to-mid single-digit royalties.","Board changes: Vishal Kapoor and Scott Brun resigned; Patrick Crutcher appointed director; Matthew Ros appointed COO."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-078887","json":"https://secwatch.observer/filing/0001213900-26-078887.json","markdown":"https://secwatch.observer/filing/0001213900-26-078887.md","text":"https://secwatch.observer/filing/0001213900-26-078887.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026078887/0001213900-26-078887-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390026078887/ea0298229-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T10:05:27.391968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}